Andrea Demitrovičová
Acute pelvic infections present urgent conditions in gynaecology and require immediate and appropriate antibiotic therapy. Infections are usually polymicrobial and chosen antibiotic regimen must therefore provide coverage against common aerobic and anaerobic bacteria. Moreover, pharmacokinetic properties and safety profile are important in the selection of optimal therapy. Ertapenem is a new carbapenem approved for complicated intraabdominal infections, acute pelvic infections, community-acquired pneumonia and complicated skin and soft tissue infections. Ertapenem is a broad-spectrum antibiotic with favourable pharmacokinetic profile. Once a day administrated ertapenem in monotherapy is effective for treatment of acute pelvic infection.